These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6697816)

  • 21. The auto-syringe infusion pump: a patient guide.
    Culnane M; Jenkins J
    Oncol Nurs Forum; 1984; 11(1):87-91. PubMed ID: 6558688
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacokinetic studies of tobramycin using the continuous intravenous infusion method (author's transl)].
    Yamasaku F; Yamada H
    Jpn J Antibiot; 1981 Nov; 34(11):1429-35. PubMed ID: 7334576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of infusion methods on tobramycin serum concentrations in newborn infants.
    Nahata MC; Powell DA; Durrell DE; Miller MA; Glazer JP
    J Pediatr; 1984 Jan; 104(1):136-8. PubMed ID: 6690658
    [No Abstract]   [Full Text] [Related]  

  • 24. Does transfusion using a syringe infusion pump and small-gauge needle cause hemolysis?
    Wilcox GJ; Barnes A; Modanlou H
    Transfusion; 1981; 21(6):750-1. PubMed ID: 7314226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fundamental and clinical studies on tobramycin by intravenous drip infusion (author's transl)].
    Toyonaga Y; Kurosu Y; Hori M
    Jpn J Antibiot; 1981 Nov; 34(11):1436-46. PubMed ID: 7334577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A miniature syringe pump for continuous administration of drugs and hormones: The Mill Hill infuser.
    Parsons JA; Rothwell D; Sharpe JE
    Lancet; 1977 Jan; 1(8002):77-8. PubMed ID: 63716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting drug delivery from a syringe-pump infusion set.
    Geater RE; Leff RD; Roberts RJ
    Am J Hosp Pharm; 1985 Nov; 42(11):2510-3. PubMed ID: 4073070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical studies on tobramycin using intravenous drip infusion (author's transl)].
    Saito A; Kikuiri T; Tomizawa M; Ujiie A; Kinoshita Y
    Jpn J Antibiot; 1981 Sep; 34(9):1255-62. PubMed ID: 7328750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between drugs and intravenous delivery systems.
    Kowaluk EA; Roberts MS; Polack AE
    Am J Hosp Pharm; 1982 Mar; 39(3):460-7. PubMed ID: 7072732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacy-initiated implementation of a syringe pump infusion system.
    Goudreau JB; Morrissey JM
    Am J Hosp Pharm; 1985 Mar; 42(3):584-7. PubMed ID: 3985022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
    de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
    Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo accuracy of gravity-flow i.v. infusion systems.
    Crass RE; Vance JR
    Am J Hosp Pharm; 1985 Feb; 42(2):328-31. PubMed ID: 3976679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A small observational study of the longevity of syringe driver sites in palliative care.
    Morgan S; Evans N
    Int J Palliat Nurs; 2004 Aug; 10(8):405-12. PubMed ID: 15365496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluations of tobramycin in treatment of chronic complicated urinary tract infections by intravenous drip infusion administration (author's transl)].
    Suzuki K
    Jpn J Antibiot; 1982 Feb; 35(2):409-20. PubMed ID: 7087177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Peripheral intravenous infusions. Reduction of morbidity owing to an electronic controller of infusion flow rate].
    Zazzo JF; Millat B; Larrieu H
    Presse Med; 1984 Feb; 13(7):427-8. PubMed ID: 6230611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syringe size and flow rate affect drug delivery from syringe pumps.
    Weiss M; Hug MI; Neff T; Fischer J
    Can J Anaesth; 2000 Oct; 47(10):1031-5. PubMed ID: 11032282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
    Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fundamental and a few clinical studies in pediatric field on tobramycin with intravenous drip infusion method (author's transl)].
    Nakazawa S; Sato H; Hirama Y; Niino K; Narita A; Nakazawa S; Chikaoka H
    Jpn J Antibiot; 1981 Aug; 34(8):1173-7. PubMed ID: 7321195
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the FASTSTART mode for reducing start-up delay in syringe pump infusion systems.
    Neff T; Fischer J; Fehr S; Baenziger O; Weiss M
    Swiss Med Wkly; 2001 Apr; 131(15-16):219-22. PubMed ID: 11400545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandole.
    Feld R; Rachlis A; Tuffnell PG; Duncan I; Moran L; Pinfold P; DeBoer G
    Arch Intern Med; 1984 May; 144(5):1005-10. PubMed ID: 6712393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.